Liver inflammation from hepatitis A (acute, food-borne), B (often chronic), or C (often chronic, now curable with antivirals). Nutrition supports liver regeneration: milk thistle, NAC, alpha-lipoic acid, and adequate protein.
Last updated:
Viral hepatitis is liver inflammation caused by one of five distinct hepatitis viruses (A, B, C, D, E). The three most important globally are hepatitis A (acute, foodborne, self-limiting), hepatitis B (can cause acute and chronic infection, vaccine preventable), and hepatitis C (often chronic, but now curable with direct-acting antivirals).
Acute viral hepatitis presents with jaundice, fatigue, nausea, and elevated liver enzymes. Most cases of hepatitis A and many cases of hepatitis B resolve spontaneously. Hepatitis C is asymptomatic in ~80% during acute infection but progresses to chronic infection in ~70-85% of those infected.
Chronic hepatitis B and C are leading causes of cirrhosis and hepatocellular carcinoma globally, together accounting for ~70% of liver cancer cases. Modern antiviral therapy has dramatically changed prognosis: hepatitis C is now curable in >95% of patients with 8-12 weeks of oral DAAs; hepatitis B can be suppressed (though rarely cured) with long-term antivirals.
Fecal-oral transmission (contaminated food/water, poor sanitation). Acute illness, no chronic form. Self-limiting in >99%. Vaccine preventable. Common in travelers to endemic areas. Lifelong immunity after infection.
Bloodborne (mainly IV drug use, pre-1992 transfusions). ~70-85% become chronic. NO vaccine yet. CURABLE in >95% with 8-12 weeks of oral DAAs (Mavyret, Epclusa). Major cause of liver cancer historically.
Acute hepatitis has characteristic prodrome followed by jaundice. Chronic infections are often asymptomatic until advanced liver disease develops.
Often the earliest and most prominent symptom. Severe, disabling. Lasts weeks to months. May persist after biochemical recovery.
Yellow eyes/skin (sclera first), dark cola-colored urine, pale clay-colored stools. Develops as bilirubin rises. May or may not appear in all cases.
Severe loss of appetite, particularly aversion to fatty foods and cigarettes (in smokers). Nausea and vomiting common. Weight loss.
Dull ache from inflamed liver stretching its capsule. Not the sharp pain of biliary disease. Hepatomegaly often palpable.
The dangerous reality of chronic HBV and HCV, many patients have NO symptoms until they develop cirrhosis or liver cancer 20-40 years after infection. This is why screening is critical.
The most common symptom when present. Disproportionate to liver enzyme levels. Significantly impacts quality of life.
Common with chronic HCV. Polyarthralgia involving small joints. Sometimes precedes other symptoms. May be mistaken for early rheumatoid arthritis.
Late presentation: ascites, jaundice, varices, hepatic encephalopathy, palmar erythema, spider angiomas. Indicates progression to cirrhosis, emergent evaluation needed.
Anti-HAV IgM, positive in acute infection. Anti-HAV IgG, positive after recovery or vaccination (immunity). Total Anti-HAV, combination.
HBsAg: active infection (acute or chronic). Anti-HBs: immunity (recovery or vaccine). Anti-HBc IgM: recent infection. Anti-HBc IgG: past or chronic. HBeAg + HBV DNA: viral replication/activity.
Anti-HCV antibody: screening test (positive = ever exposed). HCV RNA (PCR): confirms active infection (positive = currently infected). HCV genotype: guides treatment selection.
SUPPORTIVE for acute hepatitis; COMPLEMENTARY for chronic. Hep C should be CURED with DAAs first.
Anti-inflammatory, antioxidant-rich diet supports hepatocyte regeneration and slows fibrosis progression. Absolute alcohol abstinence is non-negotiable.
Broccoli, Brussels sprouts, kale, garlic, onions. Support liver Phase II detoxification (glutathione conjugation, sulfation).
Consistently shown to slow fibrosis progression in chronic hepatitis B and C. Reduces liver cancer risk. Black coffee preferred.
Omega-3 EPA/DHA reduce hepatic inflammation. 2-3 servings per week. Avoid farmed if possible.
Polyphenol and flavonoid-rich. Anti-inflammatory and antioxidant. Aim for diverse colors daily.
Eggs, fish, poultry, legumes. Liver regeneration requires amino acids. Don't restrict protein unless severe hepatic encephalopathy.
Even small amounts accelerate fibrosis dramatically in viral hepatitis. Alcohol + virus = synergistic liver damage. Complete abstinence required.
Drive hepatic steatosis on top of viral hepatitis. Doubly hard on the liver. Eliminate sodas, juices, sweets, HFCS.
Pro-inflammatory. Worsen oxidative stress in liver. Eliminate canola, corn, soybean oils; replace with olive, avocado, coconut.
Limit to <2g/day in chronic liver disease. Avoid combining with alcohol ever. Don't exceed labeled doses. Check OTC combination products.
Oysters and clams can transmit hepatitis A. Avoid raw shellfish from waters of unknown safety. Get vaccinated.
Liver-supportive supplements complement but don't replace antiviral therapy. For HCV, prioritize getting cured with DAAs.
| Supplement | Mechanism & Evidence | Suggested Dose | Timing | Notes |
|---|---|---|---|---|
| Milk Thistle (Silymarin) | Antioxidant, anti-fibrotic, hepatocyte membrane stabilizer. Modest but consistent evidence in chronic hepatitis. | 600-900mg/day (standardized to 80% silymarin) | Divided doses with meals | Best-studied herb for liver. Choose phosphatidylcholine-bound forms for bioavailability. |
| N-Acetyl Cysteine (NAC) | Glutathione precursor, replenishes liver's master antioxidant depleted in viral hepatitis. | 600-1,800mg/day | Divided doses | Also protects against acetaminophen toxicity. |
| Alpha-Lipoic Acid | Universal antioxidant; regenerates other antioxidants (vitamin C, E, glutathione). Reduces oxidative liver damage. | 300-600mg/day | Empty stomach | R-form better absorbed. May lower blood sugar. |
| Vitamin D3 | Deficiency strongly correlates with chronic hepatitis severity. Improves antiviral response, reduces inflammation. | 2,000-5,000 IU/day (titrate to 50-80 ng/mL) | With fat meal | Test baseline level. Pair with K2 200mcg. |
| Selenium | Cofactor for glutathione peroxidase. Deficient in chronic liver disease. May reduce HCC risk. | 200mcg/day | With food | Don't exceed 400mcg/day long-term. |
| Vitamin E (Mixed Tocopherols) | Antioxidant; some evidence for reducing fibrosis in chronic hepatitis (especially with steatosis). | 400-800 IU/day | With fat meal | Use mixed tocopherols, not alpha-tocopherol alone. |
| Glycyrrhizin (Licorice Root) | Anti-inflammatory, antiviral effects. Used IV in Japan for chronic hepatitis. Reduces ALT levels. | 150-300mg/day (DGL preferred for safety) | With meals | Caution: raises blood pressure, lowers potassium. DGL safer for long-term use. |
| Curcumin (Turmeric) | Anti-inflammatory, antifibrotic, hepatoprotective. Reduces oxidative stress in liver. | 500-1,500mg/day (with piperine or liposomal) | With fat meal | Standard curcumin poorly absorbed, choose bioavailable forms. |
Hepatitis C is curable. Hepatitis B is treatable. Hepatitis A is preventable. Don't let chronic viral hepatitis silently destroy your liver, get screened, address risk factors, and access modern antiviral therapy. Holistic strategies complement, never replace, evidence-based antiviral treatment.